Cerebrospinal Fluid (CSF) Management Market to reach 1.56 Billion $ by 2022

The global cerebrospinal fluid (CSF) management market is expected to reach USD 1.56 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 4.4%.

(EMAILWIRE.COM, August 03, 2018 ) Objectives of the Study

To define, describe, and forecast the global cerebrospinal fluid management market by product, end user, and region
To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
To forecast size of market segments in North America, Europe, Asia Pacific, and RoW2
To analyze the market structure and profile key players of the global CSF management market and comprehensively analyze their core competencies3
To analyze the competitive landscape of the major players operating in the CSF management market
Full Report : https://www.marketsandmarkets.com/Market-Reports/cerebrospinal-fluid-management-market-160672575.html    Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global cerebrospinal fluid management market and estimate the size of other dependent submarkets. Various secondary sources such as Food and Drug Administration (FDA), Hydrocephalus Association, World Health Organization (WHO), National Hydrocephalus Foundation (NHF), Pediatric Hydrocephalus Foundation (PHF), International Federation for Spina Bifida and Hydrocephalus (IFSBH), Hydrocephalus Clinical Research Network, Pacific Adult Hydrocephalus Center, Press Releases, Directories, Industry journals, Databases, and Annual Reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

Press Release : https://www.marketsandmarkets.com/PressReleases/cerebrospinal-fluid-management.asp 

By product, the shunts segment held the largest share of the market in 2017

By product, the cerebrospinal fluid (CSF) management market is segmented into shunts and external drainage systems.

In 2017, the shunts segment accounted for the largest share of the global market. The large share of this segment can be primarily attributed to growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries owing to shunt malfunction and infection.

By end user, the pediatric segment accounted for the largest share of the market in 2017

On the basis of end user, the cerebrospinal fluid (CSF) management market is segmented into pediatric, adult, and geriatric end users. In 2017, the pediatric segment held the largest share of the global market. The large share of this segment can be primarily attributed to high prevalence of congenital hydrocephalus along with the rising number of shunting procedures in the pediatric population.